ZWJ Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.1M Buy
224,792
+7,129
+3% +$1.66M 1.85% 17
2026
Q1
$53.2M Buy
217,663
+798
+0.4% +$186K 1.92% 20
2025
Q4
$44.9M Buy
216,865
+2,764
+1% +$547K 1.62% 24
2025
Q3
$39.7M Buy
214,101
+882
+0.4% +$151K 1.4% 29
2025
Q2
$32.6M Buy
213,219
+1,511
+0.7% +$232K 1.21% 33
2025
Q1
$35.1M Buy
211,708
+2,851
+1% +$446K 1.43% 31
2024
Q4
$30.2M Buy
208,857
+1,760
+0.8% +$273K 1.25% 34
2024
Q3
$33.6M Sell
207,097
-1,725
-0.8% -$275K 1.37% 32
2024
Q2
$30.5M Buy
208,822
+7,685
+4% +$1.14M 1.34% 33
2024
Q1
$31.8M Buy
201,137
+2,831
+1% +$451K 1.45% 32
2023
Q4
$31.1M Buy
198,306
+9,041
+5% +$1.39M 1.6% 28
2023
Q3
$29.5M Buy
189,265
+462
+0.2% +$76.2K 1.64% 28
2023
Q2
$31.3M Sell
188,803
-1,022
-0.5% -$165K 1.63% 28
2023
Q1
$29.4M Buy
189,825
+1,534
+0.8% +$248K 1.62% 29
2022
Q4
$33.3M Sell
188,291
-1,113
-0.6% -$192K 1.88% 22
2022
Q3
$30.9M Sell
189,404
-1,820
-1% -$308K 1.95% 17
2022
Q2
$33.9M Sell
191,224
-6,007
-3% -$1.07M 1.98% 14
2022
Q1
$35M Sell
197,231
-7,469
-4% -$1.27M 1.85% 21
2021
Q4
$35M Buy
204,700
+359
+0.2% +$58.8K 1.79% 22
2021
Q3
$33M Buy
204,341
+597
+0.3% +$102K 1.87% 17
2021
Q2
$33.6M Buy
203,744
+273
+0.1% +$45.2K 1.94% 17
2021
Q1
$33.4M Buy
203,471
+667
+0.3% +$108K 2.06% 14
2020
Q4
$31.9M Buy
202,804
+10,458
+5% +$1.54M 2.17% 15
2020
Q3
$28.6M Buy
192,346
+5,505
+3% +$815K 2.3% 14
2020
Q2
$26.3M Sell
186,841
-58,410
-24% -$8.51M 2.28% 15
2020
Q1
$32.2M Buy
245,251
+12,853
+6% +$1.82M 2.87% 5
2019
Q4
$33.9M Buy
232,398
+65,803
+39% +$8.93M 2.28% 11
2019
Q3
$21.6M Buy
166,595
+7,792
+5% +$1.03M 1.68% 25
2019
Q2
$22.1M Buy
158,803
+3,816
+2% +$528K 1.74% 23
2019
Q1
$21.7M Buy
154,987
+761
+0.5% +$102K 1.78% 25
2018
Q4
$19.9M Buy
154,226
+3,499
+2% +$488K 1.87% 20
2018
Q3
$20.8M Buy
150,727
+1,574
+1% +$209K 1.69% 25
2018
Q2
$18.1M Buy
149,153
+16,212
+12% +$2.02M 1.56% 32
2018
Q1
$17M Sell
132,941
-17,644
-12% -$2.38M 1.54% 29
2017
Q4
$21M Sell
150,585
-1,234
-0.8% -$172K 1.66% 26
2017
Q3
$19.7M Sell
151,819
-7,824
-5% -$1.04M 1.54% 28
2017
Q2
$21.1M Sell
159,643
-16,905
-10% -$2.16M 1.69% 21
2017
Q1
$22M Buy
176,548
+23,880
+16% +$2.85M 1.8% 17
2016
Q4
$17.6M Buy
152,668
+1,683
+1% +$194K 1.69% 22
2016
Q3
$17.8M Sell
150,985
-7,853
-5% -$953K 1.78% 21
2016
Q2
$19.3M Sell
158,838
-1,075
-0.7% -$122K 1.93% 17
2016
Q1
$17.3M Buy
159,913
+60
+0% +$6.21K 1.83% 18
2015
Q4
$16.4M Sell
159,853
-2,938
-2% -$295K 1.79% 18
2015
Q3
$15.2M Sell
162,791
-4,449
-3% -$430K 1.73% 22
2015
Q2
$16.3M Sell
167,240
-2,388
-1% -$239K 1.7% 24
2015
Q1
$17.1M Sell
169,628
-8,856
-5% -$901K 1.79% 16
2014
Q4
$18.7M Sell
178,484
-2,327
-1% -$245K 1.89% 14
2014
Q3
$19.3M Sell
180,811
-482
-0.3% -$50K 2.07% 13
2014
Q2
$19M Sell
181,293
-2,035
-1% -$206K 2.12% 12
2014
Q1
$18M Sell
183,328
-8,254
-4% -$765K 2.09% 10
2013
Q4
$17.5M Sell
191,582
-1,130
-0.6% -$104K 2.02% 13
2013
Q3
$16.7M Sell
192,712
-23,076
-11% -$2.07M 2.15% 7
2013
Q2
$18.5M Buy
+215,788
New +$18.3M 2.5% 5

Other funds holding JNJ

ZWJ Investment Counsel's JNJ Position: Q2 2026 in Review

ZWJ Investment Counsel increased its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, buying an estimated $1.66M and bringing the position to 224,792 shares worth $57.1M. The position accounts for 1.85% of the portfolio, ranked #17.

ZWJ Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,139 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • ZWJ Investment Counsel held 224,792 shares of Johnson & Johnson worth $57.1M as of Q2 2026.
  • ZWJ Investment Counsel bought 7,129 Johnson & Johnson shares in Q2 2026, an estimated $1.66M.
  • Johnson & Johnson made up 1.85% of ZWJ Investment Counsel's portfolio in Q2 2026, its #17 holding.
  • ZWJ Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,139 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.